Neogene Therapeutics
Neogene Therapeutics is a biotech company providing cancer patients with T cell therapies targeting mutated proteins called neo-antigens.
Funding reportedLast round: Series A
What company datasets say Neogene Therapeutics raised
Funding, as reported
Reported in all125Min the source's currency
Rounds2
Last roundSeries A
Last round dateSept 2020
Investors listed9
On 4 portfolio pages
Investors who name them
Each firm lists Neogene Therapeutics on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.
Biotechnology in the same market
Startups like it
Is this your company?
Add your raise, your deck and your story, and put Neogene Therapeutics in front of investors. Or tell us what we have wrong.